Related Experiment Video
Updated: Feb 2, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Mitral valve prolapse
Aeshah Althunayyan1,2, Steffen E Petersen1,2, Guy Lloyd1,2,3
1a Barts Heart Centre, St Bartholomew's Hospital , Barts Health NHS Trust , London , UK.
Abstract:
Introduction: Mitral valve prolapse (MVP) is a common valve pathology with a spectrum of disease from isolated prolapse to myxomatous, multi-scallop Barlow's disease. The main complications relate to progression of mitral regurgitation, endocarditis, sudden death, and stroke. The timing of intervention in patients with asymptomatic severe mitral regurgitation is controversial. Areas covered: This article reviews the pathophysiology, genetics, clinical features, diagnostic imaging, complications, long-term outcomes, and indications for intervention in MVP. Expert commentary: Several key dilemmas in the management of MVP remain. Factors which influence progression of mitral regurgitation are unclear and therefore, we have no therapeutic targets to prevent progression. Evidence-based methods to reduce the risk of sudden death, stroke, and endocarditis have not been identified. In symptomatic patients with severe mitral regurgitation valve surgery is recommended. In asymptomatic patients, careful risk stratification incorporating markers of left ventricular dysfunction, atrial fibrillation, pulmonary hypertension, and valve reparability is required to identify the optimal timing of intervention.
Insights
Mitral valve prolapse (MVP) management is complex. For asymptomatic severe mitral regurgitation, risk stratification is crucial to determine optimal intervention timing, as progression factors and complication prevention remain unclear.
Area of Science:
- Cardiology
- Valvular Heart Disease
Background:
- Mitral valve prolapse (MVP) is a common cardiac condition with varied severity, from isolated prolapse to Barlow's disease.
- Complications include mitral regurgitation, endocarditis, sudden cardiac death, and stroke.
- Optimal intervention timing for asymptomatic severe mitral regurgitation remains a clinical dilemma.
Purpose of the Study:
- To review the pathophysiology, genetics, clinical features, diagnostic imaging, complications, outcomes, and intervention indications for MVP.
- To discuss current challenges and controversies in MVP management.
Main Methods:
- Literature review of pathophysiology, genetics, clinical presentation, imaging, complications, and outcomes of MVP.
- Analysis of current evidence regarding indications for intervention in symptomatic and asymptomatic patients.
Main Results:
- Progression factors for mitral regurgitation in MVP are not well-defined, limiting targeted preventative therapies.
- Evidence-based strategies to mitigate risks of sudden death, stroke, and endocarditis in MVP are lacking.
- Surgical intervention is recommended for symptomatic severe mitral regurgitation.
Conclusions:
- Management of MVP requires careful risk stratification in asymptomatic patients, considering left ventricular function, atrial fibrillation, pulmonary hypertension, and valve repairability.
- Further research is needed to identify factors influencing MVP progression and to develop preventative strategies for major complications.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction

